Log in to save to my catalogue

The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016

The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6cafedd3d5d140d3b410ffa891474011

The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016

About this item

Full title

The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2023-04, Vol.21 (1), p.146-146, Article 146

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Data on the economic burden of RSV-associated illness will inform decisions on the programmatic implementation of maternal vaccines and monoclonal antibodies. We estimated the cost of RSV-associated illness in fine age bands to allow more accurate cost-effectiveness models to account for a limited duration of protection conferred by short- or long-...

Alternative Titles

Full title

The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6cafedd3d5d140d3b410ffa891474011

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6cafedd3d5d140d3b410ffa891474011

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-023-02854-2

How to access this item